XLV Among Health Care ETFs
End-of-day Nov 12, 2026 · 33 Health care ETFs by YTD
Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.6% | +1.6% | +8.0% | +12.7% | +22.8% | +26.7% | +53.8% | +51.6% | +701.3% |
| Peer average | −1.7% | +1.7% | +5.8% | +4.3% | +21.7% | +26.7% | +69.8% | +26.0% | — |
| S&P 500 · VOO | −0.3% | +3.3% | −1.6% | −2.2% | +11.9% | +12.1% | +80.1% | +73.9% | — |
$168 of every $1,000 in XLV is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly + | Healthcare | 16.79% | $1,679.46 | 5.9M | $8.54B |
| 2 | JNJJohnson + Johnson | Healthcare | 9.87% | $986.83 | 17.9M | $5.02B |
| 3 | ABBVAbbvie | Healthcare | 7.61% | $761.22 | 13.1M | $3.87B |
| 4 | MRKMerck + | Healthcare | 5.30% | $530.27 | 18.3M | $2.70B |
| 5 | UNHUnitedhealth Group | Healthcare | 5.28% | $528.17 | 6.7M | $2.69B |
| 6 | TMOThermo Fisher Scientific | Healthcare | 3.88% | $387.53 | 2.7M | $1.97B |
| 7 | AMGNAmgen | Healthcare | 3.70% | $369.57 | 4.0M | $1.88B |
| 8 | GILDGilead Sciences | Healthcare | 3.07% | $307.34 | 9.2M | $1.56B |
| 9 | ABTAbbott Laboratories | Healthcare | 2.76% | $276.17 | 12.9M | $1.40B |
| 10 | PFEPfizer | Healthcare | 2.45% | $245.12 | 42.3M | $1.25B |
| 11 | ISRGIntuitive Surgical | Healthcare | 2.32% | $231.91 | 2.6M | $1.18B |
| 12 | DHRDanaher | Healthcare | 2.15% | $214.99 | 4.6M | $1.09B |
| 13 | VRTXVertex Pharmaceuticals | Healthcare | 2.02% | $202.47 | 1.9M | $1.03B |
| 14 | BMYBristol Myers Squibb | Healthcare | 1.88% | $187.66 | 15.2M | $954.5M |
| 15 | MCKMckesson | Healthcare | 1.84% | $183.84 | 866K | $935.1M |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly + | 16.79% |
| 2 | JNJ | Johnson + Johnson | 9.87% |
| 3 | ABBV | Abbvie | 7.61% |
| 4 | MRK | Merck + | 5.30% |
| 5 | UNH | Unitedhealth Group | 5.28% |
| 6 | TMO | Thermo Fisher Scientific | 3.88% |
| 7 | AMGN | Amgen | 3.70% |
| 8 | GILD | Gilead Sciences | 3.07% |
| 9 | ABT | Abbott Laboratories | 2.76% |
| 10 | PFE | Pfizer | 2.45% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 23, 2026 | $0.64 |
| Jun 22, 2026 | Jun 24, 2026 | $0.66 |
| Mar 23, 2026 | Mar 25, 2026 | $0.59 |
| Dec 22, 2025 | Dec 24, 2025 | $0.66 |
| Sep 22, 2025 | Sep 24, 2025 | $0.62 |
| Jun 23, 2025 | Jun 25, 2025 | $0.63 |
| Mar 24, 2025 | Mar 26, 2025 | $0.56 |
| Dec 23, 2024 | Dec 26, 2024 | $0.62 |
| Sep 23, 2024 | Sep 25, 2024 | $0.58 |
| Jun 24, 2024 | Jun 26, 2024 | $0.57 |
| Mar 18, 2024 | Mar 21, 2024 | $0.52 |
| Dec 18, 2023 | Dec 21, 2023 | $0.60 |